Terrance Coughlin

Chief Operating Officer at Par Pharmaceutical Companies Inc.

Are you Terrance Coughlin? Claim your profile
 
  • IDENTIFY corporate executives in Terrance Coughlin's network and community.
  • FOLLOW changes in Terrance Coughlin's employment and money-in-motion.
  • CONNECT with Terrance Coughlin through your network of contacts.

Terrance Coughlin's Executive Bio


Current
Chief Operating Officer, Par Pharmaceutical Companies Inc.
Past
To view Terrance Coughlin's complete executive bio,
Age
-
 

Terrance Coughlin's Annual Salary, Stock and Options


Salary and Bonus
Stock Awards
Option Awards
-
-
-
 

Terrance Coughlin's Insider Transactions


Last 3 years
Option Exercised
Stock Sold
New Equity Grants
-
-
-
Next 3 years
Upcoming Wealth
Develop prospecting strategies based on upcoming wealth events.
 

Terrance Coughlin's Net Worth


Equity Holdings
To view Terrance Coughlin's total equity holdings,
 

Terrance Coughlin's Recent Events


Joined Par Pharmaceutical Companies Inc. as Chief Operating Officer
04/01/2014
New bonus target (Par Pharmaceutical Companies Inc.)
04/01/2014
Base salary $550,000 (Par Pharmaceutical Companies Inc.)
04/01/2014
 
 
To see additional events for Terrance Coughlin,
 

By accessing Equilar Atlas, you can view bios, network, salary and wealth events of industry-leading executives like Terrance Coughlin. More specifically, you'll be able to:

  • IDENTIFY corporate executives in Terrance Coughlin's network and community.
  • FOLLOW changes in Terrance Coughlin's employment and money-in-motion.
  • CONNECT with Terrance Coughlin through your network of conections.
 

Search for over 360,000 executive profiles.

/bio

Example: Terrance Coughlin

Equilar Atlas is the premier C-Suite Power Networking solution as seen in

Top 10 Executive Lists


View top 10 executives by events such as Salary, Stock Sale, Resignations, or Appointments

Popular Profiles


SVP, Corporate Development, CFO and Treasurer, Patterson-UTI Energy Inc.
Founding Scientist, President, Regeneron Laboratories & Chief Scientific Officer and Board Member, Regeneron Pharmaceuticals, Inc.